Consort announced that it has completed the acquisition of Aesica.
Consort announced that it has completed the acquisition of Aesica. According to the press release, this move is in line with Consort’s strategy to diversify its offerings and expand into adjacent drug/device markets.
The agreement to acquire Aesica was first announced at the end of September 2014. Established in 2004, Aesica provides contract development and manufacturing services for finished pharmaceutical dosage forms and APIs.
Capitalized terms have been defined in Part XVIII of the combined shareholder prospectus and circular published on 30 September 2014.
Source: Consort Medical
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.